Biocon informs about company updates

20 Mar 2020 Evaluate

Biocon has informed that the company has received the Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for the Post-Approval and GMP inspection of its Small Molecules API Manufacturing Facility at 20th KM, Biocon Campus, Bengaluru, conducted between Feb 20 and Feb 26, 2020. The EIR has been closed with a VAI classification for the observations. At the conclusion of the inspection last month the agency had issued a Form 483, with two observations, which were procedural in nature and are being addressed by the Company.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

389.95 -2.85 (-0.73%)
08-Dec-2025 11:06 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.50
Dr. Reddys Lab 1275.70
Cipla 1510.45
Zydus Lifesciences 932.05
Lupin 2092.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×